Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial — Papers | ScholarIQ

Scholar IQ

Help

Try ScholarIQ free

Upload Records Snowball Search Search OpenAlex

About the database

ScholarIQanswers from OpenAlex

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

PaperCitations, authors & open-access status

2,672

Citations

2,015

Year

closed

OA Status

IDs:DOI PMID OpenAlex

Related on ScholarIQ

Jeffrey S. Weber

Jean‐Jacques Grob

F. Stephen Hodi

Christopher D. Lao

Gerald P. Linette